Mercados españoles abiertos en 6 hrs 38 min

CardieX Limited (CDX.AX)

ASX - ASX Precio demorado. Divisa en AUD
Añadir a la lista de favoritos
0,0490+0,0010 (+2,08%)
A partir del 10:02AM AEST. Mercado abierto.

CardieX Limited

55 Lime Street
Suite 301 Level 3
Sydney, NSW 2000
Australia
61 2 9874 8761
https://cardiex.com

Sector(es)Healthcare
SectorMedical Devices
Empleados a tiempo completo

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICDCo-Founder & Executive Chairman305,19kN/A1964
Mr. Craig R. Cooper BEC, L.L.B.Co-Founder, Group CEO, MD & Executive Director785,38kN/A1964
Dr. Ahmad Qasem Ph.D.Chief Science & Research Officer217,35kN/A1964
Dr. Steven KestenChief Medical Officer202,94kN/A1958
Dr. Mark Gorelick Ph.D.Chief Product Officer377,6kN/A1975
Ms. Catherine LiaoChief Strategy Officer361,51kN/A1979
Mr. Douglas T. KurschinskiExecutive VP & Head of Global Sales for AtCor Medical Division342,61kN/AN/A
Ms. Louisa HoCompany SecretaryN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en AUD.

Descripción

CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.

Gobierno corporativo

El ISS Governance QualityScore de CardieX Limited, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.